Charles River Laboratories International, Inc.

New York Stock Exchange
Back to all articles
Neutral 0

Charles River Laboratories International Inc. stock underperforms Wednesday when compared to competitors despite daily gains

AI-generated analysis

📈 Charles River Laboratories International Inc. shares rose 1.39% to $174.90 on Wednesday, outpacing the broader market despite overall positive sentiment.

🤝 The stock's gain was part of a larger trading session where the S&P 500 climbed 0.72% and the Dow Jones Industrial Average advanced 0.48%.

🔄 This marked the third consecutive day that CRIS stock recorded gains following previous daily increases.

⚖️ Despite rising prices, CRIS stock underperformed compared to its sector competitors during Wednesday's trading session.

📊 Market data for the report was supported by Dow Jones and FactSet platforms providing intraday and historical exchange quotes.

ℹ️ The article notes that all quoted U.S. stock figures reflect trades reported through Nasdaq only with specific delay policies.

Bullish Signals
  • Shares of Charles River Laboratories International Inc. (CRL) advanced 1.39% to $174.90 on Wednesday, demonstrating positive momentum.
  • This marks the stock's third consecutive day of gains, indicating sustained upward price movement.
Risk Factors
  • The stock underperforms compared to competitors despite showing daily gains, indicating relative weakness in market sentiment.
  • No significant positive catalysts are mentioned to offset the relative underperformance against broader market indices like the S&P 500 and Dow Jones.
  • Limited information is provided regarding the company's financial fundamentals or growth prospects beyond price movement.
  • Intraday data delays of at least 15 minutes or per exchange requirements may impact timely trading decisions for investors.
Full Analysis
Charles River Laboratories International Inc. (CRL) shares advanced 1.39% to $174.90 on Wednesday, marking the stock's third consecutive day of gains. Despite the positive daily performance, the company underperformed relative to its competitors during the session. The broader market remained strong on Wednesday, with the S&P 500 Index rising 0.72% to close at 6,575.32 and the Dow Jones Industrial Average gaining 0.48% to reach 46,565.74. The news article highlights a contrast between CRL's individual stock movement and its peer group, noting that while the stock finished higher for the third day in a row, it failed to match the pace of other companies in its sector or the overall market momentum. The specific price level of $174.90 is presented against the backdrop of wider market indices reaching levels of 6,575.32 and 46,565.74 respectively. The provided text also includes standard disclosures regarding data sources, noting that intraday data is supplied by FACTSET and real-time last sale data reflects trades reported through Nasdaq. A delay disclaimer indicates that intraday data may be delayed at least 15 minutes or more depending on exchange requirements. The content was published by MarketWatch on April 1, 2026, citing partnerships with Dow Jones and FactSet for world-class markets data support.